Prognostic value of different maternal obesity phenotypes in predicting offspring obesity in a family-based cohort

Sara Jalali-Farahani1,2, Parisa Amiri3, Bita Lashkari1

  • 1Research Center for Social Determinants of Health, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, P.O.Box: 19395-4763, Tehran, Iran.

BMC Public Health
|May 9, 2021
PubMed

Insights

Maternal obesity, especially when combined with metabolic issues, significantly increases childhood obesity risk. The obese/dysmetabolic phenotype poses the highest risk, highlighting key targets for early intervention strategies.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Parental weight is a known factor in childhood obesity.
  • Metabolic abnormalities in parents are less studied as contributors to childhood obesity.
  • This study investigates maternal obesity phenotypes and their link to offspring obesity incidence.

Purpose of the Study:

  • To examine the association between maternal obesity phenotypes (considering body mass index and metabolic status) and the incidence of obesity in children.
  • To identify specific maternal obesity phenotypes that pose a higher risk for childhood obesity.
  • To inform targeted interventions for preventing childhood obesity.

Main Methods:

  • Longitudinal study within the Tehran Lipid and Glucose Study framework.
  • Followed 2151 non-obese children with complete parental data for obesity incidence.
  • Classified maternal body mass index (BMI) and defined six obesity phenotypes based on BMI and metabolic status (metabolic syndrome or diabetes).
  • Utilized Cox proportional regression hazard models to analyze associations.

Main Results:

  • Maternal overweight/obesity phenotypes, particularly when combined with dysmetabolic status, significantly increased obesity risk in both male and female offspring.
  • The obese/dysmetabolic maternal phenotype showed the highest risk for offspring obesity.
  • Maternal normal weight with dysmetabolic status did not significantly alter offspring obesity risk.

Conclusions:

  • All maternal obesity phenotypes, except for normal weight/dysmetabolic, were significant predictors of offspring obesity.
  • The obese/dysmetabolic maternal phenotype presents the highest risk for childhood obesity.
  • Findings identify critical target groups for childhood obesity prevention interventions.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
866
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
63
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
43
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
43
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K